title: Immune mechanism and clinical significance of macrophage to medullary hematopoietic injury of immune-related hematocytopenia patients.
abstract: BACKGROUND
  Immune-related hematocytopenia (IRH) is considered to be related with the production of autoantibody, as well as the activation of humoral immunity which is stimulated by B lymphocyte. This study aimed to observe the levels of various cytokines in the blood serum and the in situ active state of macrophage (Mφ) in the medullary hematopoietic microenvironment of IRH patients, and to probe into the immune mechanism and clinical significance of Mφ in hematopoietic cell injury.
  
  
  METHODS
  ELISA is used to detect the IL-4, IL-6, IL-12, IL-17, and IFN-γ levels in the peripheral blood serum of 376 patients in pre- and post-therapy. Cytochemistry and cell immunochemistry methods are used to observe the peroxidase (POX), nonspecific esterase (NSE), hemosiderin granules, and HLA-DR activity of Mφ in the bone marrow of patients. Immunofluorescence is used to observe the expression of hemocyte antihuman globulin IgG antibody, lymphocytes CD4 molecule, Mφ membrane FcγIIreceptor (FcγIIR), mannitose receptor (MR), IFN-γ, ICAM-1, IL-12, and IL-17A and the formation mechanism of antibody-dependent cell-mediated cytotoxicity (ADCC) hematopoietic cell islands (HI) in the medullary hematopoietic microenvironment of patients. Glucocorticoid is used for treatment on the basis of anti-infection therapy, and gamma globulin stoss therapy is used for the appearance of ADCC-type HI or serious Mφ bloodthirsty phenomenon; if necessary, association of Cyclosporine A (CsA) should be used and chalybeate should be supplemented.
  
  
  RESULTS
  In the patient group, the levels of IL-4, IL-6, IL-12, IL-17, and IFN-γ were increased. After treatment, the cytokine levels gradually became normal. The activated Mφ in the marrow highly expressed NSE and POX, and Mφ swallowed more hemosiderin particles, but the iron in the cytoplasm of immature erythrocytes decreased. The activated Mφ expressed HLA-DR, MR, ICAM-1, IFN-γ, and IL-12. For patients with humoral immunity activation and bacterial infection, Mφ weakly expressed IL-17A but highly expressed FcγIIR, and the phenomenon that ADCC-type HI broke pathological blood corpuscles often occurred; for the cellular immune activation along with virus infection, the white blood count (WBC) significantly reduced, Mφ weakly expressed FcγIIR, secretory highly expressed IL-17A, and the phenomena that Mφ adhered to, captured and swallowed blood cell often occurred. After four weeks of anti-infective and immunosuppressive therapy, nuclear apoptosis of Mφ occurred in the bone marrow of patients, HI and bloodthirsty phenomenon disappeared, and the peripheral blood picture started to improve.
  
  
  CONCLUSIONS
  Mφ is an important antigen presenting cell in the IRH marrow for hematopoiesis destruction and an immune effector cell of hematopoietic injury; infection can promote the activation of Mφ, upregulate the impression of immune molecule and receptors, form ADCC HI, aggravate hematopoietic injury, and accelerate the destruction on hematopoietic cell.
authors.affiliation: Department of Tumor Research and Treatment Centricity, People's Liberation Army No. 148 Hospital, Zibo, Shandong 255300, China. Email: sunlifei_2007@163.com.
authors.forename: Li-Fei
authors.initials: LF
authors.lastname: Sun
authors.affiliation: Department of Tumor Research and Treatment Centricity, People's Liberation Army No. 148 Hospital, Zibo, Shandong 255300, China.
authors.forename: Bing
authors.initials: B
authors.lastname: Han
authors.affiliation: Department of Tumor Research and Treatment Centricity, People's Liberation Army No. 148 Hospital, Zibo, Shandong 255300, China.
authors.forename: Qiang-Qiang
authors.initials: QQ
authors.lastname: Wu
authors.affiliation: Department of Tumor Research and Treatment Centricity, People's Liberation Army No. 148 Hospital, Zibo, Shandong 255300, China.
authors.forename: Xiao-Xi
authors.initials: XX
authors.lastname: Zhang
authors.affiliation: Department of Tumor Research and Treatment Centricity, People's Liberation Army No. 148 Hospital, Zibo, Shandong 255300, China.
authors.forename: Yan-Hui
authors.initials: YH
authors.lastname: DU
authors.affiliation: Department of Tumor Research and Treatment Centricity, People's Liberation Army No. 148 Hospital, Zibo, Shandong 255300, China.
authors.forename: Gui-Chen
authors.initials: GC
authors.lastname: Wang
authors.affiliation: Department of Tumor Research and Treatment Centricity, People's Liberation Army No. 148 Hospital, Zibo, Shandong 255300, China.
authors.forename: Jin-Biao
authors.initials: JB
authors.lastname: Zhang
authors.affiliation: Department of Tumor Research and Treatment Centricity, People's Liberation Army No. 148 Hospital, Zibo, Shandong 255300, China.
authors.forename: Yan
authors.initials: Y
authors.lastname: Zhang
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D007371:Interferon-gamma / Q000378:metabolism; D018664:Interleukin-12 / Q000378:metabolism; D020381:Interleukin-17 / Q000378:metabolism; D015847:Interleukin-4 / Q000378:metabolism; D015850:Interleukin-6 / Q000378:metabolism; D008264:Macrophages / Q000276:immunology* / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D010198:Pancytopenia / Q000276:immunology* / Q000378:metabolism*; D055815:Young Adult
chemical_list: D020381:Interleukin-17; D015850:Interleukin-6; D018664:Interleukin-12; D015847:Interleukin-4; D007371:Interferon-gamma